Genotyping Assay Market Report 2025 (Global Edition)

Global Genotyping Assay Market Report 2025 Market Size Split by By Product & Service Outlook: (Reagents & Kits, Genotyping Services, Instruments, Sequences & Amplifiers, Analysers, Bioinformatics, Sof...

Genotyping Assay Market Report Description

We have various report editions of Genotyping Assay Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Trump Tariffs on the Genotyping Assay Market

Genotyping assays, which rely on a global supply chain for reagents and equipment, are especially susceptible to tariffs on imported medical devices and components. Approximately 69% of medical devices marketed in the United States are manufactured entirely outside of the country, with China accounting for 13.6%. Tariffs on these imports can increase the costs of essential research tools, such as diagnostic kits and laboratory supplies, potentially reducing the number of US sites involved in international trials.

Tariffs may impede the efficient conduct of clinical trials by increasing costs and disrupting the supply chain. Hospitals and research facilities may face increased costs for supplies such as gowns, gloves, and syringes, as well as medical equipment like CT scanners and X-ray machines. This financial strain may cause a reduction in R&D budgets, delaying clinical study timelines, and potentially shifting trials to countries not affected by tariffs, such as India, South Korea, and Europe

Tariffs may cause a shift in the locations used for global clinical trials. Countries not affected by tariffs, such as India, South Korea, and European nations, may become more appealing to trial sponsors looking to cut research costs. This shift could have an impact on the United States' position as a leader in clinical research.?

Competitive Landscape of the Genotyping Assay Market

The Genotyping Assay Market is highly competitive, characterized by the presence of several global and regional players offering a wide range of products. Key companies in the market, such as GE HealthCare, Standard BioTools Inc., PerkinElmer, and Eurofins Scientific SE dominate through their extensive product portfolios, strong distribution networks, and focus on innovation.

In January 2023, Thermo Fisher Scientific has announced the release of the CE-IVD-marked Applied Biosystems TaqPath Seq HIV-1 Genotyping kit. The kit is based on the Sanger sequencing-based assay, which examines positive HIV samples for genetic variants that are resistant to common antiretroviral therapies. https://corporate.thermofisher.com/content/tfcorpsite/us/en/index/newsroom/press-releases/2022/Aug/08-Thermo-Fisher-Scientific-Launches-Enhanced-Applied-Biosystems-HIV-1-Genotyping-Kit.html" In August 2022, Bio-Rad Laboratories announced that it had acquired Curiosity Diagnostics. The acquisition will allow the company to drive innovation in the molecular diagnostics market. https://investors.bio-rad.com/press-releases/news-details/2022/Bio-Rad-Acquires-Curiosity-Diagnostics/default.aspx/" In August 2024, The Kerala government is looking into how advanced DNA sequencing technology can help identify 52 dissociated samples from Wayanad landslide victims. https://www.thehindu.com/news/national/kerala/kerala-may-use-advanced-dna-technology-to-identify-wayanad-landslides-victims/article68539938.ece/"

Top Companies Market Share in Genotyping Assay Industry: (In no particular order of Rank)

• Illumina
• Inc.
• Thermo Fisher Scientific
• QIAGEN N.V.
• Agilent
• Danaher Corporation
• Roche
• GE HealthCare
• Standard BioTools Inc.
• PerkinElmer
• Eurofins Scientific SE
• Bio-Rad Laboratories
• Pacific Biosciences of California Inc.
• GENEWIZ
• Inc.
• Integrated DNA Technologies Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Genotyping Assay Market

Which Region Dominates the Genotyping Assay Market in 2025?

According to Cognitive Market Research, North America dominates the genotyping assay market in 2023, owing to high demand for advanced genetic testing and a well-established healthcare infrastructure. The region's leadership in research and development, combined with the presence of major market players and substantial funding, strengthened its position. This dominance emphasizes North America's role as an innovation hub, attracting ongoing investments and maintaining a competitive advantage in the global market

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is expected to grow at the fastest CAGR between 2025 and 2033, owing to increased healthcare investment, expanded research initiatives, and increased awareness of genetic testing. Emerging economies in the region are adopting genotyping technologies for use in personalized medicine and agriculture. This rapid growth is poised to reshape the competitive landscape, attracting global players to seize untapped opportunities and propelling regional genomics advancements

The current report Scope analyzes Genotyping Assay Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Genotyping Assay Market Analysis

According to Cognitive Market Research, the global Genotyping Assay Market size was estimated at USD 19.4 Million, out of which North America held the major market share of more than 37% of the global revenue with a market size of USD 7.18 million in 2025 and will grow at a compound annual growth rate (CAGR) of 12.0% from 2025 to 2033.

United State Genotyping Assay Market size is USD 5.66 million in 2025

According to Cognitive Market Research, the US had a major share in the Genotyping Assay Market with a market size of USD 5.66 million in 2025 and is projected to grow at a CAGR of 11.8% during the forecast period. Growing adoption of technologically advanced products drives United State Genotyping Assay Market.

Canada Genotyping Assay Market size is USD 0.86 million in 2025

The Canadian Genotyping Assay Market had a market share of USD 0.86 million in 2025 and is projected to grow at a CAGR of 12.8% during the forecast period. Rising prevalence of chronic diseases drives Canada Genotyping Assay Market.

Mexico Genotyping Assay Market size is USD 0.65 million in 2025

The Mexico Genotyping Assay Market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 0.65 million in 2025..

Europe Genotyping Assay Market Analysis

According to Cognitive Market Research, The global Genotyping Assay Market size was estimated at USD 19.4 Million, out of which Europe held the market share of more than 29% of the global revenue with a market size of USD 2538.7 million in 2025 and will grow at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2033.

United Kingdom Genotyping Assay Market size is USD 0.95 million in 2025

The United Kingdom Genotyping Assay Market had a market share of USD 0.95 million in 2025 and is projected to grow at a CAGR of 13.3% during the forecast period. Growing prevalence of cardiovascular and genetic disorders drives United Kingdom Genotyping Assay Market.

France Genotyping Assay Market size is USD 0.52 million in 2025

The France Genotyping Assay Market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 0.52 million in 2025.

Germany Genotyping Assay Market size is USD 1.11 million in 2025

According to Cognitive Market Research, the German Genotyping Assay Market size was valued at USD 1.11 million in 2025 and is projected to grow at a CAGR of 12.7% during the forecast period. Increased investment in genotyping research drives Germany Genotyping Assay Market.

Italy Genotyping Assay Market size is USD 0.48 million in 2025

The Italy Genotyping Assay Market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 0.48 million in 2025.

Russia Genotyping Assay Market size is USD 0.87 million in 2025

The Russia Genotyping Assay Market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 0.87 million in 2025

Spain Genotyping Assay Market size is USD 0.46 million in 2025

The Spain Genotyping Assay Market is projected to witness growth at a CAGR of 11.6% during the forecast period with a market size of USD 0.46 million in 2025

Sweden Genotyping Assay Market size is USD 0.17 million in 2025

The Sweden Genotyping Assay Market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 0.17 million in 2025.

Denmark Genotyping Assay Market size is USD 0.12 million in 2025

The Denmark Genotyping Assay Market is projected to witness growth at a CAGR of 12.3% during the forecast period, with a market size of USD 0.12 million in 2025

Switzerland Genotyping Assay Market size is USD 0.08 million in 2025

The Switzerland Genotyping Assay Market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 0.08 million in 2025.

Luxembourg Genotyping Assay Market size is 0.07 million in 2025

The Luxembourg Genotyping Assay Market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 0.07 million in 2025.

Rest of Europe Genotyping Assay Market size is USD 0.79 million in 2025

The Rest of Europe's Genotyping Assay Market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 0.79 million in 2025.

Asia Pacific Genotyping Assay Market Analysis

According to Cognitive Market Research, the global Genotyping Assay Market size was estimated at USD 19.4 Million, out of which APAC held the market share of around 24% of the global revenue with a market size of USD 15165.3 million in 2025 and will grow at a compound annual growth rate (CAGR) of 16.2% from 2025 to 2033.

China Genotyping Assay Market size is USD 1.96 million in 2025

The China Genotyping Assay Market size was valued at USD 1.96 million in 2025 and is projected to grow at a CAGR of 15.7% during the forecast period. Genotyping Assay Market surged in China due to growing number of government initiatives.

Japan Genotyping Assay Market size is USD 0.64 million in 2025

The Japan Genotyping Assay Market is projected to witness growth at a CAGR of 14.7% during the forecast period, with a market size of USD 0.64 million in 2025

South Korea Genotyping Assay Market size is USD 0.56 million in 2025

The South Korea Genotyping Assay Market had a market share of USD 0.56 million in 2025 and is projected to grow at a CAGR of 15.3% during the forecast period. The presence of skilled healthcare professionals drives South Korea Genotyping Assay Market.

India Genotyping Assay Market size is USD 0.47 million in 2025

The Indian Genotyping Assay Market is projected to witness growth at a CAGR of 18.1% during the forecast period, with a market size of USD 0.47 million in 2025.

Australia Genotyping Assay Market size is USD 0.24 million in 2025

The Australian Genotyping Assay Market is projected to witness growth at a CAGR of 15.5% during the forecast period, with a market size of USD 0.24 million in 2025.

Singapore Genotyping Assay Market size is USD 0.09 million in 2025

The Singapore Genotyping Assay Market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 0.09 million in 2025.

Taiwan Genotyping Assay Market size is USD 0.18 million in 2025

The Taiwan Genotyping Assay Market is projected to witness growth at a CAGR of 16.0% during the forecast period, with a market size of USD 0.18 million in 2025.

South East Asia Genotyping Assay Market size is USD 0.31 million in 2025

The South East Asia Genotyping Assay Market is projected to witness growth at a CAGR of 17.0% during the forecast period, with a market size of USD 0.31 million in 2025.

Rest of APAC Genotyping Assay Market size is USD 0.21 million in 2025

The Rest of APAC Genotyping Assay Market is projected to witness growth at a CAGR of 16.0% during the forecast period, with a market size of USD 0.21 million in 2025.

South America Genotyping Assay Market Analysis

According to Cognitive Market Research, the global Genotyping Assay Market size was estimated at USD 19.4 Million, out of which South America held the market share of around 3.8% of the global revenue with a market size of USD 0.74 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2033.

Brazil Genotyping Assay Market size is USD 0.32 million in 2025

The Brazil Genotyping Assay Market size was valued at USD 0.32 million in 2025 and is projected to grow at a CAGR of 13.8% during the forecast period. The prevalence of neurological disorders drives Brazil Genotyping Assay Market.

Argentina Genotyping Assay Market size is USD 0.12 million in 2025

Argentina's Genotyping Assay Market had a market share of USD 0.12 million in 2025 and is projected to grow at a CAGR of 14.1% during the forecast period. The presence of skilled healthcare professionals drives Argentina Genotyping Assay Market.

Colombia Genotyping Assay Market size is USD 0.07 million in 2025

Colombia Genotyping Assay Market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 0.07 million in 2025

Peru Genotyping Assay Market size is USD 0.06 million in 2025

Peru Genotyping Assay Market is projected to witness growth at a CAGR of 13.4% during the forecast period, with a market size of USD 0.06 million in 2025.

Chile Genotyping Assay Market size is USD 0.05 million in 2025

Chile Genotyping Assay Market is projected to witness growth at a CAGR of 13.5% during the forecast period, with a market size of USD 0.05 million in 2025

Rest of South America Genotyping Assay Market size is USD 0.12 million in 2025

The Rest of South America's Genotyping Assay Market is projected to witness growth at a CAGR of 12.3% during the forecast period, with a market size of USD 0.12 million in 2025.

Middle East Genotyping Assay Market Analysis

According to Cognitive Market Research, the global Genotyping Assay Market size was estimated at USD 19.4 Million, out of which the Middle East held the major market share of around 4% of the global revenue with a market size of USD 0.78 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2033..

Qatar Genotyping Assay Market size is USD 0.06 million in 2025

The Qatar Genotyping Assay Market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 0.06 million in 2025. High healthcare awareness drives Qatar Genotyping Assay Market.

Saudi Arabia Genotyping Assay Market size is USD 0.27 million in 2025

The Saudi Arabia Genotyping Assay Market is projected to witness growth at a CAGR of 13.8% during the forecast period, with a market size of USD 0.27 million in 2025.

Turkey Genotyping Assay Market size is USD 0.06 million in 2025

The Turkey Genotyping Assay Market is projected to witness growth at a CAGR of 14.1% during the forecast period, with a market size of USD 0.06 million in 2025. Proliferation of academic institutes drives Turkey Genotyping Assay Market.

UAE Genotyping Assay Market size is USD 0.16 million in 2025

The UAE Genotyping Assay Market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 0.16 million in 2025.

Egypt Genotyping Assay Market size is USD 0.05 million in 2025

The Egypt Genotyping Assay Market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 0.05 million in 2025.

Rest of the Middle East Genotyping Assay Market size is USD 0.17 million in 2025

The Rest of the Middle East Genotyping Assay Market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 0.17 million in 2025

Africa Genotyping Assay Market Analysis

According to Cognitive Market Research, the global Genotyping Assay Market size was estimated at USD 19.4 Million, out of which the Africa held the major market share of around 2.20% of the global revenue with a market size of USD 0.43 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2025 to 2033.

Nigeria Genotyping Assay Market size is USD 0.03 million in 2025

The Nigeria Genotyping Assay Market is projected to witness growth at a CAGR of 14.1% during the forecast period, with a market size of USD 0.03 million in 2025. Genotyping Assay Market sales flourish due to growing prevalence of infectious diseases

South Africa Genotyping Assay Market size is USD 0.15 million in 2025

The South Africa Genotyping Assay Market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 0.15 million in 2025.

Rest of Africa Genotyping Assay Market size is USD 0.24 million in 2025

The Rest of Africa Genotyping Assay Market is projected to witness growth at a CAGR of 13.1% during the forecast period, with a market size of USD 0.24 million in 2025.

Genotyping Assay Market Analysis

How are Segments Performing in the Global Genotyping Assay Market?

Genotyping Assay Market Product & Service Segment Analysis

According to Cognitive Market Research, the reagents & kits segment dominates the genotyping assay market as it is a key component in laboratory processes that analyze DNA to determine the presence of specific variants. Genotyping reagents include DNA polymerases, primers, and other materials, whereas kits include genotyping kits, BeadChip kits, and other items. To identify loci of the sequence, these reagents or kits use the target DNA sequence and compare it to the ideal DNA sequence. For instance, in April 2024, Bio-Rad launched the ddPLEX ESr1 Mutation Detection Kit, a multiplexed digital PCR assay for breast cancer mutation detection. The assay was designed to provide highly sensitive and multiplexed mutation detection assays for translational research, therapy selection, and disease monitoring. This new kit provides oncology researchers with technologies that aid in biomarker discovery and clinical trials, thereby improving patient monitoring

Bioinformatics is the fastest-growing segment of the genotyping assay market. This refers to the tools, software, and analytical services required to interpret, process, and manage massive amounts of data generated by genotyping assays. The demand for advanced bioinformatics solutions grows dramatically as genotyping technologies advance. They are critical for deriving meaningful knowledge from complex genomic data, thereby advancing personalized medicine, drug development, and agrigenomics applications. Bioinformatics is the fastest-growing segment of the genotyping assay market, owing to the growing demand for data interpretation and analysis skills

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Genotyping Assay Industry. Request a Free Sample PDF!

Genotyping Assay Market Technology Segment Analysis

According to Cognitive Market Research, the PCR genotyping assay has the largest market share due to its high accuracy, speed, and cost. The growing demand for advanced diagnostic techniques, the increasing number of chronic disease disorders, forensic and research laboratories, and the rising prevalence of genetic disorders are all driving the genotyping assay market. For instance, Elsevier B.V. published an article in February 2024 that highlights the study, which researchers from the University of Cambridge conducted in collaboration with the National Health Service (NHS) and other public health institutions in the United Kingdom. Researchers developed RT-PCR assays that specifically target the genetic markers associated with SARS-CoV-2 variants. These assays sought to identify a key mutation in the spike protein by comparing genotyping and whole genome sequencing of variants to provide sensitive and specific results

In the Genotyping Assay Market, the Sequencing segment has been expanding at a rapid pace. It is expected to grow at a rapid pace during the forecast period due to improved specificity and the ability to detect low expression and differentially expressed genes compared to other approaches. Genotyping by sequencing also allows for comparative analysis of samples without the need for a reference genome

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Genotyping Assay By Application Outlook: Segment Analysis

Genotyping Assay Market Application Segment Analysis

According to Cognitive Market Research, the diagnostics and personalised medicine segment will account for the largest share in 2025, owing to the increasing adoption of genotyping products for research and the growing need for genetic disease diagnosis. Furthermore, strategic collaborations between players are expected to drive market growth. For instance, in February 2019, Centogene formed a strategic partnership with Sarepta Therapeutics, Inc. to diagnose Duchenne muscular dystrophy patients in the Middle East and North Africa.

Pharmacogenomics is expected to have the highest CAGR between 2025 and 2033. Genotyping identifies patients who are suitable for a particular drug based on their genetic makeup. Identifying population subsets that are responsive or non-responsive allows for tailor-made treatment for these individuals with different genetic makeups, reducing clinical trial attrition. Furthermore, key players take an active role in providing solutions for pharmacogenomics studies.

• Pharmacogenomics
• Diagnostic & Personalised Medicine
• Agricultural Biotechnology
• Animal Genetics
• Others (Prenatal Testing
• Human Forensics
• Microbial Genomic Studies
• Aquaculture Breeding Studies
• etc.)

Genotyping Assay By End-user Outlook: Segment Analysis

• Pharmaceutical & Biopharmaceutical Companies
• Diagnostic & Research Laboratories
• Academic Institutes
• Others (Animal and Aquagenetics Companies
• etc.)

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion